Beating Heart Transplant Procedures Using Organs From Donors With Circulatory Death

Aravind Krishnan1, Chawannuch Ruaengsri1, Brandon A Guenthart1

  • 1Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.

JAMA Network Open
|March 11, 2024
PubMed

Insights

The beating heart method for deceased donor (DCD) heart transplants is safe, showing zero need for extracorporeal membrane oxygenation post-surgery. This technique may reduce ischemia reperfusion injury, improving outcomes for DCD heart transplantation.

Area of Science:

  • Cardiovascular Surgery
  • Transplantation Immunology
  • Organ Preservation

Background:

  • Deceased after circulatory death (DCD) donors are increasingly used for heart transplantation.
  • Ex vivo normothermic organ perfusion enables DCD heart use but involves ischemia, potentially increasing graft injury.
  • High rates of extracorporeal membrane oxygenation (ECMO) are observed post-DCD heart transplant.

Purpose of the Study:

  • To evaluate the safety of the beating heart method for DCD heart transplantation.
  • To assess the postoperative rate of extracorporeal membrane oxygenation (ECMO) use in DCD heart transplantation using this technique.

Main Methods:

  • A case series of 10 patients undergoing DCD heart transplantation using the beating heart implantation method.
  • Data collected from October 2022 to August 2023 at a single academic medical center.
  • Analysis focused on primary graft dysfunction and need for mechanical circulatory support.

Main Results:

  • All 10 patients survived with 100% graft survival.
  • No patients required postoperative extracorporeal membrane oxygenation (ECMO) or other mechanical circulatory support.
  • The mean age of recipients was 51.2 years, with 70% having idiopathic dilated cardiomyopathy.

Conclusions:

  • The beating heart implantation method for DCD heart transplantation is safe and effective.
  • This technique may mitigate ischemia reperfusion injury, potentially reducing primary graft dysfunction and ECMO requirement.
  • Findings are relevant for centers utilizing DCD donors for heart transplantation.
Abstract